Related Experiment Videos
The influence of thrombolytic therapy on the predictive value of exercise testing 3 weeks after acute myocardial
1Department of Cardiology, Rambam Medical Centre, Faculty of Medicine, Haifa, Israel.
Insights
Exercise testing after acute myocardial infarction (AMI) may not effectively identify high-risk patients for intervention when thrombolytic therapy is used. ST-segment depression predicted events in non-thrombolysis patients, but not in those receiving thrombolysis.
Area of Science:
- Cardiology
- Clinical Exercise Physiology
Background:
- Early risk stratification after acute myocardial infarction (AMI) is crucial for guiding post-discharge management.
- Thrombolytic therapy has become a standard treatment for AMI, potentially altering the prognostic value of traditional exercise tests.
Purpose of the Study:
- To assess the prognostic utility of submaximal exercise testing performed three weeks post-AMI in patients treated with thrombolysis.
- To compare the predictive value of exercise test findings between patients who received thrombolytic therapy and those who did not.
Main Methods:
- A prospective 1-year follow-up study of 185 patients who survived AMI and received thrombolytic therapy, compared with 272 controls not receiving thrombolysis.
- Exercise testing was conducted three weeks after AMI, with ST-segment deviations analyzed for correlation with clinical outcomes and thrombolytic treatment.
Main Results:
- In patients treated with thrombolysis, only ST-segment elevation during exercise predicted cardiac events.
- Conversely, ST-segment depression of ≥1 mm during exercise in non-thrombolysis patients was associated with significantly higher cardiac event rates (12.3% vs. 3.9%, P < 0.05).
Conclusions:
- Exercise testing shortly after AMI may have limited ability to identify high-risk patients needing early intervention when thrombolytic therapy has been administered.
- The prognostic significance of exercise-induced ST-segment changes appears to differ based on whether thrombolytic therapy was used during the acute phase of infarction.
Objectives:
To evaluate the prognostic value of exercise testing performed soon after acute myocardial infarction (AMI) in patients treated with thrombolytic therapy.
Design:
A 1-year prospective follow-up of 185 subjects treated with thrombolytic therapy who survived AMI, and who performed exercise testing 3 weeks after AMI. These patients were compared with 272 patients not receiving thrombolytic therapy during the same period.
Subjects:
Patients recovering from AMI, without medical contraindications to exercise testing performed 3 weeks after AMI.
Main Outcome Measures:
ST-segment deviations during exercise testing 3 weeks post-AMI were related to clinical outcome 1-year post-AMI and to the administration of thrombolytic therapy during the acute phase of infarction.
Results:
In patients treated with thrombolytic therapy, the only exercise-test-related parameter predicting subsequent cardiac events was ST-segment elevation. In contrast, patients not receiving thrombolytic therapy and demonstrating ST-segment depression of > or = 1 mm during exercise had more clinical cardiac events than those without this finding (12.3 vs. 3.9%; P < 0.05).
Conclusion:
This study casts doubt on the ability of exercise testing to select a high-risk population requiring early intervention to prevent recurrent coronary events after thrombolysis for AMI.